Past Events
Host of Annual In-Person Emerging Medtech Summit
(recognized as the must-attend event by thought-leading strategics & VCs)
Current Event
Welcome to Q3 2017 Emerging Medical Technologies Spotlight.
Access from your Desktop on October 27, 2017 10am PT
BedLab
Rodolfo Ferraresi
BioDirection
Eric Goorno
Biobeat
Remote patient monitoring platform leveraging AI to continuously monitor 13 health parameters
Arik Ben Ishay
CardioThrive
Shelley Savage
Chief Executive Officer
DoseVue
Emiliano D Agostino
EVAV TECHNOLOGIES
Luiz Mauricio
Eyevensys
Non-viral technology that allows a safe local sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases
Patricia Zilliox
CEO & President
Glucorecs
John Viguerie
ID-Nest Medical
Christophe Tezenas du Montcel
IGI Technologies
William Plishker
IVDiagnostics
Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
Frank Szczepanski
Cofounder & Chairman
Intent Solutions
Sam Zamarripa
KelaHealth
Software-as-a-Service (SaaS) that uses machine learning for predicting surgery complication risk and deploying risk modification interventions for surgeons
Bora Chang
CEO & Founder
Medical 21
Manny Villafaña
Chief Executive Officer
Mespere Lifesciences
Xuefeng Cheng
Aidar Health
A single integrated device, MouthLabTM and cloud-based proprietary mobile application that is used to create a unique ‘biosignature’, composed of multiple digital biomarkers that intelligently reflects an individual’s true health; we call it Aidar COVIDTM. Our transformative rapid health assessment device, MouthLab, a non-invasive, at home, rapid health assessment device measures 10+ vital health parameters, such as oral temperature (TEMP), blood pressure (BP), respiratory rate (RR), respiratory flow cycle morphology (RFM), pulse rate (PR), three-lead electrocardiography (ECG), functional oxygen saturation of arterial hemoglobin (SpO2), heart rate (HR), heart rate variability (HRV), spirometer (SPIRO) or lung functions (FEV1, FVC, FEV1/FVC, PEF) and voice in just 30 seconds.
Sathya Elumalai
CEO
N8 Medical
Robert Mitchell
CEO
Neurosteer
Cloud-based platform that utilizes advanced brain signal processing and big data analytics for mobile, continuous monitoring and management of brain health and wellness
Nathan Intrator
CEO
NIDO
A medical device company developing SEPIA, an innovative solution for epicardial VT ablation that has been initiated by two investigators at Boston Children’s Hospital and Harvard Medical School. SEPIA will allow safe access and real-time visualization of the epicardial surface. Ultimately it will reduce complications and improve ablation efficiency, leading to decrease recurrence of VT.
Thomas Marchand
Chief Executive Officer
Olympus
We are seeking safe and efficient solutions that deliver minimally invasive treatment in the following fields:
-Flexible endoscopic procedures in the Gastrointestinal & Respiratory fields
-Laparoscopic surgery & Gynecological surgery in the General Surgery field
-Flexible or rigid endoscopic procedures in the Urology & Gynecology fields
-Flexible endoscopic procedures in the Ear, Nose and Throat field
Please contact us: medtech_innovation@Olympus.com
(Note) Any ideas, documents or information submitted in contacting us should be on a non-confidential basis. All ideas must have a patent filing.
Olympus -
Pulmostics
Breath analysis diagnostic systems using advanced biomarker analytical technology and data analysis algorithms for next generation point of care diagnosis and management of disease
William Wittmeyer
Founder & CEO
Patrona Medical
James Conner
PerfAction Technologies
Shy Zyman
Semler HealthPerks
Herbert Semler
Sonavex
David Narrow
Chief Executive Officer
Transverse Medical
Cerebral embolic protection for transcatheter aortic valve replacement (TAVR), cardiovascular percutaneous interventions and surgical procedures
Eric Goslau
CEO
Ulbrich
Ulbrich provides solutions for the most challenging design and manufacturing specifications. Our extensive metallurgical staff and medical product managers are available to assist you in providing various stainless, nitinol, niobium, nickel, titanium and cobalt alloys in the form of precision rolled strip, foil, round, flat and shaped wire for all your medical device needs.
Ulbrich -
Vybion
Lee Henderson
Ximedica
For more than 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Ximedica was formed in 1985 by two Rhode Island School of Design (RISD) graduates, Aidan Petrie and Stephen Lane. From those earliest days to today, the application of "human-centered" design thinking to the innovation and product creation processes remains central to the company's success. In 2014 SV Life Sciences purchased a majority stake in the firm, recognizing that Ximedica is unique in providing a comprehensive service platform - a much needed option in the evolving ecosystem of outsourced medical device development. Throughout its history Ximedica has unearthed new opportunities for clients, solved difficult development challenges, delivered cutting edge innovative solutions and added considerably to patent counts. www.ximedica.com
Joe Gordon
Director of Innovation
Medcura
Jim Buck
CEO, Director, President